# Siesta Medical, Inc.

> Siesta Medical, Inc. is a privately held medical device company in Los Gatos, California that builds minimally invasive implants and instruments to treat obstructive sleep apnea (OSA). Its flagship AIRLIFT procedure - performed with the FDA-cleared Encore System and the Revolution Suture Passer - lets ear, nose and throat surgeons pull the hyoid bone and tongue base forward to keep the airway open during sleep. The knotless, fully adjustable approach takes roughly 30 minutes, works regardless of a patient's anatomy, BMI or apnea severity, and has been used in more than 2,000 patients.

- **Founded:** 2009
- **Headquarters:** Los Gatos, California, United States
- **Founders:** Peter Martin (Co-founder, President & CEO), Erik van der Burg (Co-founder, Chairman & CTO), Michael Kolber (Co-founder, VP Regulatory Affairs & Clinical Research), Chris Feezor (Co-founder, VP of R&D)
- **Team size:** Approximately 6 employees
- **Products:** AIRLIFT Procedure, Encore System, Revolution Suture Passer
- **Notable:** FDA 510(k) clearance for the Encore Tongue Suspension System (September 2011)., FDA clearance for hyoid suspension with the Encore System (March 2014) - the only knotless, fully adjustable hyoid suspension system on the market., FDA clearance for expanded Encore System indications (May 2019).

## Products & services

- **AIRLIFT Procedure** — A minimally invasive, roughly 30-minute outpatient surgery in which the hyoid bone and/or tongue base are suspended forward to prevent airway collapse during sleep. Performed by otolaryngologists (ENT surgeons).
- **Encore System** — An integrated set of implants and instruments for hyoid and tongue-base suspension. The only knotless and fully adjustable hyoid suspension system cleared by the FDA, usable regardless of patient anatomy, BMI or OSA severity.
- **Revolution Suture Passer** — A specialized surgical instrument that simplifies passing and placing sutures during the AIRLIFT procedure, improving precision and control.

## Achievements

- FDA 510(k) clearance for the Encore Tongue Suspension System (September 2011).
- FDA clearance for hyoid suspension with the Encore System (March 2014) - the only knotless, fully adjustable hyoid suspension system on the market.
- FDA clearance for expanded Encore System indications (May 2019).
- Additional FDA 510(k) clearance granted December 22, 2021 (K213159).
- More than 2,000 patients treated with the AIRLIFT procedure.
- Multicenter study showed a median 74% reduction in apnea-hypopnea index (AHI 49.9 to 15.4); 84% of severe patients improved to mild or moderate.

## Latest updates

- **2021-12** — Received additional FDA 510(k) clearance (K213159) for the Encore System for anterior advancement of the tongue base and hyoid suspension.
- **2019-05** — FDA cleared expanded indications for the Encore System for broad obstructive sleep apnea treatment.
- **2015-03** — Launched the Revolution Suture Passer for use with the Encore System.
- **2014-03** — FDA cleared the Encore System for hyoid suspension, the only knotless, fully adjustable system of its kind.

## Links

- Website: https://siestamedical.com
- LinkedIn: http://www.linkedin.com/company/siesta-medical-inc.
- YouTube: https://www.youtube.com/channel/UC8MlGp7ZN70PWCbi_XPoUZA
- Facebook: https://www.facebook.com/Siestamedicalsleep/

---

Profile page: https://yespress.io/siesta-medical-inc
Published by YesPress — https://yespress.io
Last updated: 2026-06-12